{"product_id":"soterahealth-five-forces-analysis","title":"Sotera Health Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFrom Overview to Strategy Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eSotera Health operates in a consolidation-driven, regulation-heavy market where pricing pressure from large healthcare buyers and the bargaining power of specialized suppliers shape margins; competitive rivalry is intense among global sterilization and lab services providers while barriers to entry remain moderate due to capital intensity and accreditation requirements. This brief snapshot only scratches the surface—unlock the full Porter's Five Forces Analysis to explore Sotera Health’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of Cobalt-60 Supply\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Cobalt-60 supply is highly concentrated among a few reactor operators, limiting Nordion’s sourcing and making Sotera Health reliant on long-term contracts and modest vertical integration; in 2024 roughly 70–80% of global Cobalt-60 capacity traced to five reactor sites, so maintenance or geopolitical disruption can sharply cut supply. This scarcity gives primary producers strong pricing power—spot premiums rose ~30% in 2023—and risks for Sotera’s gamma sterilization margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Equipment and Technology Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe manufacture of electron beam and gamma sterilization systems relies on a few specialized vendors, giving suppliers strong leverage over Sotera Health; global market for sterilization equipment was about $1.2bn in 2024, concentrated among \u0026lt;5 major suppliers. These vendors supply proprietary tech essential for regulatory compliance and uptime, so replacement risks revenue loss. High switching costs, installation downtime of weeks\/months, and multi-million-dollar capex make changing partners costly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStringent Regulatory Compliance for Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers of Ethylene Oxide and other sterilants face strict EPA and OSHA rules, shrinking qualified vendors and raising switching costs; only a handful of global chemical producers meet 2025 emission-control and safety standards. \u003c\/p\u003e\n\u003cp\u003eThat regulatory barrier keeps supplier concentration high—estimated HHIs in specialty sterilant markets exceed 2,500—so Sotera Health must keep tight contracts and contingency stocks to avoid disruptions. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnergy and Utility Dependence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSterilization plants need large, reliable power and water, so local utility providers wield strong bargaining power over Sterera Health (Sotera Health) through pricing and service terms.\u003c\/p\u003e\n\u003cp\u003eFacilities are hard to relocate or fuel-switch, locking in exposure to utility monopolies; global energy price swings—oil up ~45% 2021–2022, natural gas volatility through 2025—have squeezed margins.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003eHigh energy intensity: autoclaves, ethylene oxide, radiation systems\u003c\/li\u003e\n\u003cli\u003eLow supplier substitutability: local monopolies\u003c\/li\u003e\n\u003cli\u003e2023–2025 price shocks raised COGS pressure\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Labor and Technical Expertise\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpthe requirement for highly trained microbiologists nuclear technicians and regulatory experts narrows sotera healths talent pool driving up wage benefits demands as healthcare faces persistent shortages bureau of labor statistics data to may show a projected growth in clinical lab roles tightening supply.\u003e\n\u003cpsotera must spend more on hiring and retention surveys in put specialized recruitment premium at of base salary nelson labs sterigenics risk service delays compliance gaps.\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003eHigh dependency on niche skills\u003c\/li\u003e\u003cli\u003e5–7% role growth (BLS, May 2024)\u003c\/li\u003e\u003cli\u003eRecruitment premium 10–25% (2024 surveys)\u003c\/li\u003e\u003cli\u003eHigher retention spend to avoid compliance risk\u003c\/li\u003e\n\u003c\/psotera\u003e\u003c\/pthe\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier dominance fuels sterilization market: cobalt shortages, high premiums, rising labor\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold strong power: Cobalt-60 concentrated (70–80% at five reactors, 2024), spot premiums +30% (2023); sterilization equipment market ~$1.2bn (2024) with \u0026lt;5 major vendors; specialty sterilant HHI \u0026gt;2,500 (2025); utilities local monopolies; skilled labor growth 5–7% (BLS May 2024) raising recruitment costs 10–25% (2024 surveys).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003eKey stat\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCobalt-60\u003c\/td\u003e\n\u003ctd\u003e70–80% at 5 reactors (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpot premium\u003c\/td\u003e\n\u003ctd\u003e+30% (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEquipment market\u003c\/td\u003e\n\u003ctd\u003e$1.2bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSterilant HHI\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;2,500 (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLabor growth\u003c\/td\u003e\n\u003ctd\u003e5–7% (BLS May 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored exclusively for Sotera Health, this Porter's Five Forces overview uncovers competitive drivers, supplier\/buyer power, substitution risks, and entry barriers—identifying threats and opportunities to protect market share and inform strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Sotera Health Porter’s Five Forces one-sheet—quickly spot supplier\/customer leverage, rivalry intensity, and entrant\/substitute threats to guide strategic responses.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Switching Costs and Regulatory Linkage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCustomers face high switching costs because sterilization methods are often specified in FDA and global regulatory filings; changing providers requires costly re-validation and can delay time-to-market by months, per industry estimates of $0.5–$2M and 3–9 months for process re-validation (2024–25 data).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of Large Healthcare Clients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa significant portion of sotera health revenue according to company disclosures from a handful global medical device and pharma giants giving those buyers large volume-based leverage. these customers push for tiered pricing stricter service-level agreements often securing discounts on contract renewals. regulatory lock-in limits switching but volume consolidation still grants strong negotiating power.\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCriticality of Sterilization Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSterilization is mission-critical and largely price-inelastic: manufacturers cannot ship regulated medical devices or pharmaceuticals without validated sterilization, so demand stays stable even if prices rise. Customers often accept price increases to protect market access; Sotera reported 2024 sterilization revenue of $1.1bn, underscoring steady demand and pricing power. During surge periods, service criticality shields Sotera from intense customer-driven price pressure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDemand for Integrated Lab Testing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCustomers now prefer end-to-end solutions combining sterilization, microbiological testing, and advisory services; demand for integrated lab testing grew ~12% CAGR 2019–2024 in medical device customers per industry reports.\u003c\/p\u003e\n\u003cp\u003eBy bundling Nelson Labs with core services, Sotera builds a sticky ecosystem that raises switching costs and reduces unbundling; integrated contracts now represent an estimated 38% of Sotera revenue in 2024.\u003c\/p\u003e\n\u003cp\u003eThis shifts bargaining power toward Sotera: buyers value single-source convenience and lower regulatory risk, so price sensitivity drops and renewal rates climb (renewal \u0026gt;90% in 2024).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIntegrated testing demand +12% CAGR (2019–2024)\u003c\/li\u003e\n\u003cli\u003eIntegrated contracts ≈38% of 2024 revenue\u003c\/li\u003e\n\u003cli\u003eCustomer renewal \u0026gt;90% in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTransparency and Sustainability Demands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eModern healthcare buyers push Sotera Health to show strong ESG (environmental, social, governance) credentials; 72% of health systems stated sustainability influences vendor selection in a 2024 EY survey, so customers can steer Sotera toward cleaner tech like X-ray sterilization.\u003c\/p\u003e\n\u003cp\u003eThat buyer pressure raises Sotera’s capex and operational priorities: switching to X-ray can cost tens of millions per facility but reduces emissions and regulatory risk, giving customers leverage over procurement and pricing.\u003c\/p\u003e\n\u003cp\u003eNot meeting sustainability expectations risks losing contracts to greener rivals; a 2023 market study found 18% of purchasing decisions shifted to suppliers with lower carbon footprints.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e72% of health systems: sustainability matters (EY, 2024)\u003c\/li\u003e\n\u003cli\u003eX-ray retrofit: tens of millions per facility\u003c\/li\u003e\n\u003cli\u003e18% purchasing shift to greener suppliers (2023 study)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentrated Buyers Hold Leverage; Bundles \u0026amp; ESG Keep Sotera’s Pricing Resilient\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuyers have strong leverage from concentration and regulatory switching costs—re-validation typically costs $0.5–$2M and 3–9 months (2024–25); top customers drove ~40–50% of Sotera’s 2024 revenue, securing 5–15% discounts. Critical, price-inelastic demand and bundled services (≈38% revenue, \u0026gt;90% renewals in 2024) partially shift power back to Sotera, while ESG pressure (72% of health systems) forces capex choices.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue from top customers\u003c\/td\u003e\n\u003ctd\u003e40–50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSterilization revenue\u003c\/td\u003e\n\u003ctd\u003e$1.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntegrated contracts\u003c\/td\u003e\n\u003ctd\u003e≈38%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRenewal rate\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRe-validation cost\/time\u003c\/td\u003e\n\u003ctd\u003e$0.5–$2M; 3–9 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealth systems valuing sustainability\u003c\/td\u003e\n\u003ctd\u003e72%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eSotera Health Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Sotera Health Porter’s Five Forces analysis you'll receive immediately after purchase—no placeholders or mockups, fully formatted and ready for use. It covers supplier and buyer power, competitive rivalry, threat of substitutes, and barriers to entry with actionable insights. Once you buy, you’ll get instant access to this same professional document. Use it as-is for strategy, valuation, or presentation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747438866809,"sku":"soterahealth-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/soterahealth-five-forces-analysis.png?v=1772198491","url":"https:\/\/matrixbcg.com\/products\/soterahealth-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}